Wednesday, June 10, 2026

Intelligence · Patents

Patents expiring in 2028

Annual patent cliff calendar for 2028 — US pharmaceutical patents by expiration date.

Patents
624

Quick answer

624 indexed pharmaceutical patents have expiration dates in 2028. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7396860

    Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7396918

    IGF-I fusion polypeptides and therapeutic uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7396682

    Method for cell adhesion and wound healing

    REGENBiotech, Inc. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 7396542

    Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 7396664

    VEGF-binding fusion proteins and nucleic acids encoding the same

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7399485

    Rapidly Disintegrable solid preparation

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7399606

    Methods for identifying IκB Kinase (IKK) inhibitors

    The Regents of the University of California · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 7399827

    Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 7399823

    Antimicrobial theta defensins and methods of using same

    The Regents of the University of California · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 7399863

    Amino-substituted ethylamino β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 7399862

    5-HT4 receptor agonist compounds

    Theravance, Inc. · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 7399465

    Pharmaceutical compositions for treating arthritis and inflammatory disease

    The Regents of the University of California · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 7399488

    Abuse-deterrent pharmaceutical compositions of opiods and other drugs

    Collegium Pharmaceutical, Inc. · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 7399612

    VEGF-binding fusion proteins and nucleic acids encoding the same

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 7399759

    1, 3-benzothiazinone derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 7399750

    Methods for cardiac gene transfer

    The Regents of the University of California · Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 7402299

    Intracorporeal medicaments for photodynamic treatment of disease

    Provectus Pharmatech, Inc. · Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 7402673

    Diamine β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 7402567

    Treatment of disease by inducing cell apoptosis

    The United States of America as represented by the Department of Veterans Affairs, Office of the General Counsel (024) · Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 7402659

    Thymic stromal lymphopoietin receptor molecules and uses thereof

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA · Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 7402595

    JNK inhibitor

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 7402590

    Spiroazacyclic compounds as monoamine receptor modulators

    ACADIA Pharmaceuticals Inc. · Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 7402578

    Methods for inhibiting cognitive deterioration in adults with down's syndrome

    Corcept Therapeutics Incorporated · Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 7405286

    Stars—A muscle-specific actin-binding protein

    The Board of Regents of the University of Texas System · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 7405302

    5-lipoxygenase-activating protein (FLAP) inhibitors

    AMIRA PHARMACEUTICALS, INC. · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 7405266

    Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof

    Nektar Therapeutics AL, Corporation · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 7405233

    Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 7405202

    CRISP polypeptides as contraceptives and inhibitors of sperm capacitation

    Regents of the University of Minnesota · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 7405199

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 7404961

    Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins

    The United States of America as represented by the Secretary of the Army · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 7404954

    Methods of targeting agents to cells expressing the polymeric immunoglobulin receptor

    The Regents of the University of California · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 7405041

    Methods for regulating transcription by targeting quadruplex DNA

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 7404956

    Immunoglobulin chimeric monomer-dimer hybrids

    Syntonix Pharmaceuticals, Inc. · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 7405314

    Compounds and methods for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 7405287

    Method of treating a cancer

    The Board of Regents of the University of Texas System · Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 7408075

    Synthesis of phosphocholine ester derivatives and conjugates thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 7407964

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 7407939

    Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics

    CureGenics Ltd. · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 7407935

    Ricin toxin A-chain fragment for use as a vaccine

    The United States of America as represented by the Secretary of the Army · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 7407976

    Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 7407656

    PSCA: prostate stem cell antigen and uses thereof

    The Regents of the University of California · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 7407962

    Heteroaryl compounds useful as inhibitors or protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 7407664

    Peptide vaccines against group A streptococci

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 7407658

    Vaccines for blocking transmission of plasmodium vivax

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 7410665

    Coated implantable medical device

    Cook Regentec LLC · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 7410644

    Recombinant pox virus for immunization against tumor-associated antigens

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 7411076

    Coumarin derivative

    Institute of Medicinal Molecular Design, Inc. · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 7410758

    Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN

    The Board of Regents of the University of Texas System · Granted Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2028?

624 published patents in our USPTO index have expiration dates falling in calendar year 2028.